Author

Joaquin Poza Cordon 1

1 Hospital Universitario La Paz, IdiPaz,Madrid,Spain

A multicentric study on the effectiveness of anti-TNF agents in symptomatic stricturing Crohn's disease

Iago Rodríguez-Lago, Javier Del Hoyo, Alexandre Perez Girbes, Alejandro Garrido-Marín, Maria José Casanova, Maria Chaparro Sanchez, Agnes Fernandez Clotet, Jesus Castro Poceiro, María José García García, Sara Sánchez, Rocío Ferreiro-Iglesias, Iria Baston, Marta Piqueras, Raquel Mena, Lola Esteba i Bech de Careda, Cristina Su

ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH CLINICAL, BIOLOGICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN´S DISEASE

Marta Cuadros Martínez, Cristina Suárez Ferrer, Joaquin Poza Cordon, Eduardo Martín-Arranz, Maria Sanchez-Azofra, Jose Luis Rueda García, Laura García Ramirez, Patricia Mayor Delgado, Maria Angeles Ruiz-Ramirez, María Dolores Martín-Arranz

ADALIMUMAB TROUGH LEVELS DURING INDUCTION ARE NOT ASSOCIATED WITH BIOCHEMICAL REMISSION IN PATIENTS WITH CROHN’S DISEASE

Laura García Ramírez, Tamara Verges, María Dolores Martín-Arranz, Jesús Noci, Cristina Suárez Ferrer, Eduardo Martín-Arranz, Joaquin Poza Cordon, Jose Luis Rueda García, Maria Sanchez-Azofra, Paula Blanco San Miguel, Jose Manuel Belmonte Rodríguez

ANTI-TNF SERUM CONCENTRATIONS ARE ASSOCIATED WITH ENDOSCOPIC REMISSION IN CROHN´S DISEASE

Marta Cuadros Martínez, Cristina Suárez Ferrer, Joaquin Poza Cordon, Eduardo Martín-Arranz, Maria Sanchez-Azofra, Jose Luis Rueda García, Laura García Ramirez, Patricia Mayor Delgado, Maria Angeles Ruiz-Ramirez, María Dolores Martín-Arranz

CLINICAL CHARACTERISTICS AND PROGNOSIS OF COVID-19 IN A SPANISH COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

Maria Sanchez-Azofra, Cristina Suárez Ferrer, Eduardo Martín-Arranz, Jose Luis Rueda García, Joaquin Poza Cordon, Laura García Ramirez, Jesus Noci Belda, María Dolores Martín-Arranz

COMPARISON OF SERUM ADALIMUMAB TROUGH LEVELS IN 40MG WEEKLY VS 80MG EVERY TWO WEEKS INTENSIFICATION REGIMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Eduardo Martín-Arranz, Cristina Suárez Ferrer, Laura García Ramirez, Joaquin Poza Cordon, Maria Sanchez-Azofra, Jose Luis Rueda García, Tamara Verges, Belen Poladura, Pilar Nozal Aranda, María Dolores Martín-Arranz

INFLIXIMAB TROUGH LEVELS IN THE INDUCTION PHASE ARE ASSOCIATED WITH PROLONGED REMISSION IN CROHN´S DISEASE PATIENTS.

María Dolores Martín-Arranz, Marta Jaquotot Herranz, Eduardo Martín-Arranz, Ana Martínez Feito, Mariana Díaz-Almirón, Cristina Suárez Ferrer, Joaquin Poza Cordon, Silvia Gómez Senent, Laura García Ramirez, Mezcua Perez Aracelia, Dora Pascual-Salcedo

INTESTINAL ULTRASOUND FEATURES ASSOCIATED WITH RESPONSE TO ADALIMUMAB IN PATIENTS WITH CROHN’S DISEASE

Jesús Noci, Tamara Verges, Eduardo Martín-Arranz, Maria Sanchez-Azofra, Joaquin Poza Cordon, Jose Luis Rueda García, Cristina Suárez Ferrer, Laura García Ramírez, María Dolores Martín-Arranz, Paula Blanco San Miguel, Jose Manuel Belmonte Rodríguez

OPTIMIZATION OF DOSES OF THIOPURINIC DRUGS (AZATIOPRINE AND MERCAPTOPURINE) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER TREATMENT COMBINED WITH ANTI-TNF alpha (INFLIXIMAB/ADALIMUMAB)

Javier Lucas Ramos, Cristina Suárez Ferrer, María Dolores Martín-Arranz, Joaquin Poza Cordon, Eduardo Martín-Arranz, Irene Andaluz Garcia, Jorge Yebra Carmona, Pedro Mora Sanz

SERUM PREVALENCE OF SARS-COV2 ANTIBODIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE VACCINATION

Maria Sanchez-Azofra, Cristina Suárez Ferrer, Laura García Ramírez, Joaquin Poza Cordon, Isabel María Spigarelli De Rábago, Eduardo Martín-Arranz, Tamara Verges Martínez-Meco, Carolina Georgina S Suárez Cabredo, Jesus Noci Belda, María Hernández Pérez, Dolores Montero Vega, Jose Luis Rueda García, María Dolores Martín-Arranz

Item 1 - 10 / 12
1
2